Table 1.
Univariate an multivariate analysis for prediction of clinical end-points.
| All population (n = 40) | All cause of death, invasive ventilation, thromboembolic event (n = 9) |
p | |
|---|---|---|---|
| Univariate analysis | |||
| Age (y) | 71.6 ± 13.4 | 1.06 (0.98–1.15) | 0.132 |
| Sex (male) | 28 (70) | 1.66 (0.29–9.52) | 0.565 |
| BMI (Kg/m2) | 26.1 ± 4.6 | 0.98 (0.79–1.22) | 0.917 |
| BNP (pg/ml) | 471 (138–867) | 1.00 (0.99–1.01) | 0.428 |
| Hs-TnI (ng(ml) | 28.2 (10.7–80.1) | 0.99 (0.99–1.00) | 0.665 |
| At least 2 RF n(%) | 26 (65) | 2.21 (0.39–12.46) | 0.368 |
| LVEF < 35% (%) | 9 (22.5) | 0.97 (0.64–5.82) | 0.981 |
| p/f ratio | 254 ± 130.2 | 1.01 (0.99–1.01) | 0.829 |
| GGO stage + parenchymal consolidation n, (%) | 9 (22.5) | 1.64 (0.34–7.80) | 0.529 |
| Total lung disease at CT (%) | 15.1 (9.8–25.1) | 1.06 (1.01–1.11) | 0.022 |
| All population (n = 40) | All cause of death, Invasive ventilation, and thromboembolic event (n = 9) |
p | |
| Multivariate analysis | |||
| Age (y) | – | 1.05 (0.97–1.15) | 0.177 |
| Total lung disease at CT (%) | – | 1.06 (1.01–1.11) | 0.034 |
Values are n (%), mean ± SD or median (IQR) as appropriate.
BMI = body mass index; BNP = brain natriuretic peptide; LVEF = left ventricle ejection fraction; CT = computed tomography.